Low-voltage-activated T-type calcium channels are essential contributors to neuronal physiology where they play complex yet fundamentally important roles in shaping intrinsic excitability of nerve cells and neurotransmission. Aberrant neuronal excitability caused by alteration of T-type channel expression has been linked to a number of neuronal disorders including epilepsy, sleep disturbance, autism, and painful chronic neuropathy. Hence, there is increased interest in identifying the cellular mechanisms and actors that underlie the trafficking of T-type channels in normal and pathological conditions. In the present study, we assessed the ability of Stac adaptor proteins to associate with and modulate surface expression of T-type channels. We report the existence of a Ca v 3.2/Stac1 molecular complex that relies on the binding of Stac1 to the amino-terminal region of the channel. This interaction potently modulates expression of the channel protein at the cell surface resulting in an increased T-type conductance. Altogether, our data establish Stac1 as an important modulator of T-type channel expression and provide new insights into the molecular mechanisms underlying the trafficking of T-type channels to the plasma membrane.
Introduction
T-type channels are low-voltage-activated calcium channels widely expressed throughout the nervous system (for review see 1 ). Their low activation threshold makes these channels perfectly suited to operate around the resting electrical membrane potential of neurons where they play an essential role in regulating cellular excitability. They provide a "window current" that supports passive Ca 2C entry, 2 which contributes to the resting membrane potential, 3 and influencing the excitability threshold of nerve cells. Although a significant fraction of T-type channels are inactivated at rest, their recovery from inactivation during brief periods of hyperpolarization generates rebound burst of action potentials that contribute to various forms of neuronal rhythmogenesis. [4] [5] [6] [7] [8] In addition, their ability to associate with and modulate a number of potassium channel conductances further positions T-type channels to shape and fine tune the firing of nerve cells. [9] [10] [11] [12] Besides their implication in the control of intrinsic neuronal excitability, T-type channels also associate with the vesicular release machinery to support a lowthreshold form of exocytosis. 13, 14 Aberrant expression of T-type channels has been reported in a number of pathological situations including painful neuropathy arising from diabetes, [15] [16] [17] [18] inflammatory, 19 and nerve injury conditions. 20 In addition, up-regulation of T-type channels is responsible for epileptic seizures in several rodent models of epilepsy. [21] [22] [23] [24] [25] [26] Although a number of signaling pathways regulating T-type channel activity have been reported, 27 the molecular mechanisms and signaling molecules controlling the trafficking, sorting, and expression of the channel protein at the plasma membrane remain largely unknown.
Stac proteins form a family of SH3 and cysteine-rich domain-containing proteins whose primary functions remain largely unknown. 28 Three genes encode for mammalian Stac proteins (Stac1, ¡2, and ¡3) with specific tissue expression profiles. Stac3 is essentially expressed in skeletal muscle where it plays an important role in the trafficking of Ca v 1.1 channels, 29, 30 and is therefore essential for the assembly of the excitationcontraction coupling machinery 31, 32 and the maturation of skeletal muscle cells. 33 In contrast, Stac1 and Stac2 are primarily found in nerve cells, including a number of subset of DRG neurons. 34 For instance, transcripts for Stac1 were found predominantly in nociceptive peptidergic neurons, whereas Stac2 was identified in a subset of nonpeptidergic nociceptors, in trkB C neurons, and in a subpopulation of proprioceptive neurons. 34 Stac1 and Stac2 are also present in different brain regions including the cerebellum and fore-/midbrain.
Given the implication of T-type channels in neuronal excitability, and the abundance of Stac in nerve cells, we assessed the ability of Stac1 to associate with and modulate expression of Ca v 3.2 channels. We reveal the existence of a Stac1/Ca v 3.2 T-type calcium channel molecular complex that relies on the binding of Stac1 to the amino-terminal region of the channel. This interaction of Stac1 with Ca v 3.2 modulates Ttype currents by enhancing expression of the channel protein at the cell surface.
Results

Stac1 associates with Ca v 3.2 channels
To determine whether T-type calcium channels and Stac associate at the protein level, we performed coimmunoprecipitations from tsA-201 cells expressing GFP-tagged human Ca v 3.2 channels (GFP-hCa v 3.2) together with mCherry-tagged Stac1 (mCherry-Stac1). Specific anti-GFP antibody precipitated GFP-hCa v 3.2 with mCherry-Stac1, revealing the existence of a Stac1/Ca v 3.2 molcular complex (Fig. 1A) . To identify the Ca v 3.2 molcular determinants of Stac1 interactions, we assessed the ability of several intracellular regions of hCa v 3.2 to interact with Stac1. The main cytoplasmic domains of hCa v 3.2 fused to the GFP (Fig. 1B) were co-expressed in tsA-201 cells with Myctagged Stac1 (Myc-Stac1). Co-immunoprecipitation experiments revealed that Stac1 specifically immunoprecipitated with the amino-terminal region of hCa v 3.2 channels (Fig. 1C) . To further map the binding of Stac1 within the amino-terminal region of hCa v 3.2, co-immunoprecipitation experiments were performed using GFP-tagged fusion proteins corresponding to the proximal (amino acids 1-50) and distal (amino acids 51-100) regions of the aminoterminal domain of hCa v 3.2 (Fig. 1B) . As shown in Figure 1D , Stac1 specifically interacted with the distal region of the hCa v 3.2 N-terminal domain.
Collectively, these results demonstrate the existence of a Ca v 3.2/Stac1 complex that relies on the binding of Stac1 to the distal region of the amino-terminal domain of the channel.
Stac1 modulates surface expression of hCa v 3.2 channels
To analyze whether binding of Stac1 to hCa v 3.2 affects expression of the channel at the plasma membrane, we examined expression of hCa v 3.2 channels by immunostaining, using an exofacial hemagglutinin (HA)-tagged hCa v 3.2 (HA-hCa v 3.2). The expression of HA-hCa v 3.2 was quantified from low-magnification images obtained from non-permeabilized and permeabilized cells to assess surface and total expression of the channel, respectively ( Fig. 2A) . Immunostaining from non-permeabilized cells revealed a 67% increased (p 0.001) surface expression of hCa v 3.2 in cells expressing Stac1 (Fig. 2B ). In contrast, the total expression of the channel assessed from permeabilized cells expressing Stac1 remained unchanged compared to cells expressing the channel alone, suggesting that Stac1 enhanced surface expression of T-type channels independently of an effect on the overall expression levels of the channel protein.
To confirm the functional expression of T-type channels at the cell surface, we performed patch-clamp recordings on tsA-201 cells expressing hCa v 3.2 channels. Representative Ba 2C current traces in response to 150 ms depolarizing steps to values ranging between ¡90 mV and C30 mV, from a holding potential of ¡100 mV, are shown in Figure 2C for hCa v 3.2 and hCa v 3.2/Stac1-expressing cells. Figure 2D shows the corresponding mean peak Ba 2C current density as a function of membrane voltage. Consistent with the increased surface expression of hCa v 3.2 in the presence of Stac1, T-type currents recorded from cells expressing Stac1 were significantly increased compared to cells expressing the channel alone. For instance, in response to a depolarizing pulse to 30 mV, the mean peak current density was increased by 52% (p 0.001) in cells expressing Stac1 Altogether, these data indicate that Stac1 is an important chaperone of hCa v 3.2 that enhances the steady-state expression of the channel at the plasma membrane.
Discussion
In contrast to high-voltage-activated calcium channels whose trafficking and cell surface expression are controlled by their co-assembly with ancillary b-and a 2 d-subunits, 35, 36 little is known about the molecular mechanisms and chaperone proteins involved in the expression of T-type channels. In the present study, we provide evidence for an important role of Stac in the control of T-type channel expression, and demonstrate that Stac1 forms a molecular complex with Ca v 3.2 that modulates surface expression of the channel.
Previous studies have reported a role of post-translational modifications, including asparagine-linked glycosylation and ubiquitination, in the control of T-type channel expression at the plasma membrane. [37] [38] [39] [40] Moreover, the cytoplasmic I-II loop, in addition to its role in modulating gating properties of T-type channels, 41, 42 was shown to influence the trafficking of the channel to the cell surface. 43 29, 30 There are different ways by which Stac1 may affect surface expression of hCa v 3.2 channels. Indeed, the steady-state expression of T-type channels at the cell surface results from a balance between channels arriving at and being removed from the plasma membrane. One possible mechanism is that Stac1 could increase forward trafficking of the channel to the plasma membrane, possibly by masking an intracellular retention motif. However, no consensus endoplasmic reticulum retention motif is present in the aminoterminal region of hCa v 3.2. Alternatively, the increased surface expression of hCa v 3.2 channels in the presence of Stac1 could have resulted from an increased stability of the channel at the cell surface. Such a mechanism has been proposed for Ca v 1.2 and Ca v 2.2 channels where the ancillary b-subunit prevents ubiquitination and proteasomal degradation of the channel protein, and resulting in an increased expression of the channel. 45, 46 Such a mechanism is perhaps unlikely for Ca v 3.2 channels for at least 2 reasons. First, Ca v 3.2 channels are ubiquitinated in the intracellular III-IV linker, 40 ,47 a region distant from the amino-terminal domain where Stac1 interacts with the channel. Second, if Stac1 had interfered with the proteasomal degradation of the channel, an increased total expression of the channel would have been expected. Nevertheless, regardless of the exact molecular mechanisms by which Stac1 enhances Ttype channel expression, and given the importance of T-type channels in shaping neuronal electrical signals, the effect of Stac1 on the density of Ca v 3.2 channels at the cell surface is likely to have important consequences on neuronal excitability.
In summary, our data provide compelling evidence for an important role of Stac1 in the control of T-type channel expression at the plasma membrane, and enrich our understanding of the structural determinants and signaling molecules involved in the expression of T-type channels. 0 (reverse). The PCR products were inserted into the XhoI/HindIII sites of the pEGFP-C1 vector. The coding sequence of Stac1 was isolated from mouse cortex cDNA. Primers were selected according to Genebank NM_016853. Briefly, a forward primer containing the KpnI restriction site upstream the start codon (5GGTACCATGATTCCTCCAAGTGGCGCCCGC3) and a reverse primer containing the BamHI restriction site before the stop codon (5GGATCCATCACGTCT ACCAGTACATCCAGT3) were used to amplify by PCR the coding sequence of Stac1 (1209 bp), and the PCR product was inserted into KpnI/BamHI sites of the pc-GFP vector. The Stac1-GFP construct was then used as a PCR template to generated mCherry-tagged and Myc-tagged Stac1 constructs using the following primers: 5 0 GAGCTCGAGTAATGATTCCTCCAAGT GGCGC3 0 (forward) and 5 0 CTTAAGCTTTCACACG TCTACCAGTACATC3 0 (reverse). The PCR product was inserted into the XhoI/HindIII sites of the pEGFP-C1 vector. The GFP encoding sequence was then removed by NheI/XhoI sites and replaced by the mCherry encoding sequence amplified using the following primers: 5 0 TCCGCTAGCGCTACCGGTCGC CACCATGGTGAGCAAGGGCGAGGAGGATAAC AT3 0 (forward) and 5 0 TACTCGAGATCTGAGTCCG GACTTGTACAGCTCGTCCATGCCCCGGT3 0 (reve rse) or by the Myc encoding sequence amplified using the following primers: 5 0 TCCGCTAGCGCTACCGGT CGCCACCATGGAACAAAAACTCATCTCAGAA GAGGATCTGGCTCGAGTAG3 0 and 5 0 CTACTCGA GCCAGATCCTCTTCTGAGATGAGTTTTTGTTC CATGGTGGCGACCGGTAGCG CTAGCGGA3
Material and methods
Plasmid cDNA constructs
0 . All final constructs were verified by sequencing of the full-length cDNA.
Cell culture and heterologous expression
Human embryonic kidney tsA-201 cells were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum and 1% penicillin/streptomycin (Invitrogen), and maintained under standard conditions at 37 C in a humidified atmosphere containing 5 % CO 2 . Cells were transfected with plasmid cDNAs encoding Ca v 3.2 channel together with Stac1 using the calcium phosphate method.
Immunoprecipitation
Co-immunoprecipitations were performed 72 h after transfection. Cells were solubilized in 600 mL of lysis buffer (50 mM Tris/HCl, 0.05 mM EDTA, 10 mM Chaps; pH 7.5) supplemented with protease inhibitors cocktail (Roche). After sonication, cell lysates were cleared by centrifugation at 12000 g for 25 min. All steps were carried out at 4 C. Lysates were incubated for 3h with 5 mL of biotinylated mouse monoclonal anti-Myc antibody or for 16 h with 1 mL of mouse monoclonal anti-GFP antibody (antibodies were obtained from Santa Cruz Biotechnology), and then for 45 min with streptavidin beads or protein G beads (Invitrogen) at 4 C, and washed twice with PBS/ Tween-20 buffer, and twice with PBS. Beads were resuspended in 25 mL Laemmli buffer.
SDS-PAGE and immunoblot analysis
Immunoprecipitation samples, or total cell lysates (25 mg), were separated on 12 % or 4-20 % gradient (for Ca v 3.2) SDS-PAGE and transferred onto PVDF membrane (Millipore). For detection of the mCherrytagged proteins, the membrane was incubated with a primary rabbit polyclonal anti-mCherry antibody (Abcam) diluted at 1:10.000; GFP-tagged proteins were detected with a primary rabbit polyclonal anti-GFP antibody (Abcam) diluted at 1:10.000; Myctagged Stac1 was detected with a biotinylated primary mouse monoclonal anti-Myc antibody (Santa Cruz Biotechnology) diluted at 1:2000. Membranes were then washed in PBS/Tween-20 buffer, and incubated with a secondary anti-rabbit HRP-conjugated antibody (Jackson ImmunoResearch) diluted at 1:10.000 or with the NeutrAvidin Protein HRP-conjugated (ThermoFisher Scientific) diluted at 1:10.000. For immunoprecipitation controls, membranes were stripped to remove antibodies in a stripping buffer (0.2 M glycine, 1 % SDS; pH 2.0) and then reblotted as described above. Immunoreactive bands were detected by enhanced chemiluminescence.
Surface immunostaining
Twenty-four hours before the experiment, cells expressing HA-hCa v 3.2 channels were seeded on poly-L-lysine-coated glass coverslips. Cells were incubated for 30 min at 37 C with a primary monoclonal mouse anti-HA antibody (Abcam) diluted in DMEM at 1:1000, washed with PBS, fixed for 7 min in 4 % paraformaldehyde, and blocked for 45 min in blocking buffer (5 % FBS in PBS). Cells were then incubated for 1 h at room temperature with a secondary goat polyclonal anti-mouse Alexa488-conjugated antibody (Jackson ImmunoResearch) diluted in blocking buffer at 1:1000, washed, and mounted on microscope glass slides with ProLong Gold mounting medium (Life Technologies). Confocal images were acquired at low magnification with a Zeiss LSM780 microscope and the field fluorescence intensity was analyzed using ImageJ software. In order to visualize intracellular channels, cells were permeabilized with 0.2 % Triton X-100 for 10 min before incubation with the secondary antibody.
Patch-clamp electrophysiology
Patch-clamp recordings were performed 72 h after transfection in the whole-cell configuration of the patch-clamp technique at room temperature (22) (23) (24) C) in a bath solution containing (in millimolar): 5 BaCl2, 5 KCl, 1 MgCl2, 128 NaCl, 10 TEA-Cl, 10 Dglucose, 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (pH7.2 with NaOH). Patch pipettes had a resistance of 2-4 MV when filled with a solution containing (in millimolar): 110 CsCl, 3 Mg-ATP, 0.5 Na-GTP, 2.5 MgCl2, 5 D-glucose, 10 EGTA, and 10 HEPES (pH7.4 with CsOH). Whole-cell patch-clamp recordings were performed using an Axopatch 200B amplifier (Axon Instruments). Acquisition and analysis were performed using pClamp 10 and Clampfit 10 software, respectively (Axon Instruments). Ba 2C currents were recorded in response to 150 mslong depolarizing to various potentials applied every 5 s from a holding potential of ¡100 mV. The linear leak component of the current was corrected online and current traces were digitized at 10 kHz, and filtered at 2 kHz. The voltage dependence of the peak Ba 2C current density was fitted with the following modified Boltzmann equation:
with I(V) being the peak current amplitude at the command potential V, Gmax the maximum conductance, Vrev the reversal potential, V 0.5 the half-activation potential, and k the slope factor.
Statistical analysis
Data values are presented as mean § SEM for n experiments. Statistical significance was determined using Student's unpaired t test: Ã p < 0.05, ÃÃ p < 0.01, ÃÃÃ p < 0.001, and NS: statistically not different.
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